A. Retrospective approach (N = 111) | |||||||||||||||
 | Model 1 | Model 2 | Model 3 | ||||||||||||
Valuable | B | B SE | β | P value | 95% COI for B | B | B SE | β | P value | 95% COI for B | B | B SE | β | P value | 95% COI for B |
(Constant) | 153.90 | 5.22 | Â | Â | Â | 120.09 | 10.50 | Â | Â | Â | 88.75 | 15.10 | Â | Â | Â |
Fatty tissue | 1.80 | 0.38 | 0.41 | <0.001 | 1.06–2.55 | 1.61 | 0.36 | 0.37 | <0.001 | 0.89–2.32 | 1.11 | 0.39 | 0.26 | 0.005 | 0.34–1.89 |
Tumor size |  |  |  |  |  | 1.51 | 0.41 | 0.31 | <0.001 | 0.69–2.33 | 1.54 | 0.40 | 0.31 | <0.001 | 0.75–2.33 |
Gender |  |  |  |  |  |  |  |  |  |  | 20.60 | 7.33 | 0.25 | 0.006 | 6.07–35.13 |
R2 | Â | Â | Â | 0.175 | Â | Â | Â | Â | 0.266 | Â | Â | Â | Â | 0.317 | Â |
B. Transperitoneal approach (N = 64) | |||||||||||||||
 | Model 1 |  | |||||||||||||
Valuable | B | B SE | β | P value | 95% COI for B | ||||||||||
(Constant) | 166.14 | 6.90 | Â | Â | Â | ||||||||||
Fatty tissue | 1.22 | 0.44 | 0.33 | 0.008 | 0.34–2.10 | ||||||||||
R2 | Â | Â | Â | 0.110 | Â |